{"id":"W4328049371","doi":"10.1038/s41416-023-02226-w","title":"Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancer","year":2023,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Pfizer Canada; Université de Montréal; Pfizer","keywords":"Carboplatin; Triple-negative breast cancer; Cancer research; Micrometastasis; Medicine; Metastasis; PARP inhibitor; Breast cancer; Oncology; Cancer; Internal medicine; Chemotherapy; Biology; Poly ADP ribose polymerase; Cisplatin","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001132943,0.0002846957,0.0003982723,0.0002193191,0.0001208373,0.0002943405,0.0001871689,0.0001582461,0.001295542],"category_scores_gemma":[0.0001038411,0.0001318724,0.0002171084,0.0001525615,0.0001174622,0.0001210599,0.000162938,0.0004798291,0.0002172714],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000363992,"about_ca_system_score_gemma":0.0002645736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001767201,"about_ca_topic_score_gemma":0.004399821,"domain_scores_codex":[0.9998972,0.00001342871,0.000008078434,0.00002032112,0.00002966755,0.00003124425],"domain_scores_gemma":[0.9999404,0.000008565704,0.00001105308,0.000006866241,0.00000711232,0.00002588531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001068884,0.0004476412,0.001248356,0.0001082452,0.00003795934,0.00009682919,0.00001650214,0.0004181109,0.9850894,0.0000433042,0.0002337041,0.01119113],"study_design_scores_gemma":[0.0003006644,0.01080551,0.02053922,0.00001623774,0.0001299625,0.001146275,0.00004484694,0.002968769,0.9606469,0.00004067075,0.003352488,0.000008478644],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958717,0.002189609,0.0005898032,0.00004704935,0.00002024205,0.00004252619,0.0001143032,0.00004820434,0.00107647],"genre_scores_gemma":[0.9974157,0.0008232364,0.0006457753,0.00002183372,0.00000666549,0.00002822783,0.0001981572,0.000006838423,0.0008536042],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001767201,"threshold_uncertainty_score":0.004333973,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01551840970692442,"score_gpt":0.2916539065383922,"score_spread":0.2761354968314678,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}